Marketing Research

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

Market research vies for more of pharma's ear

Market research vies for more of pharma's ear

By

Suppliers are touting a deeper level of analysis, in some cases bypassing the market-research function and reaching the highest levels of their pharma clients.

IMS to go public, says acquisitions possible

IMS to go public, says acquisitions possible

By

The data and analytics giant is looking to launch an IPO. The company, which is the subject of an antitrust suit, said in its prospectus that it anticipates future acquisitions.

Amgen bone-builder bests older meds: trial

Amgen bone-builder bests older meds: trial

By

Mid-stage data show the drug, romosozumab, was associated with significant increases in bone mineral density compared to Lilly's Forteo and off-patent Fosamax.

Research tool taps patient KOLs via mobile

Research tool taps patient KOLs via mobile

By

The first on-demand way to tap the influencer community in healthcare went live today, and results of a real-world test show it has the potential to accelerate the research process.

Study reveals doc detail preferences: Hang up the phone

Study reveals doc detail preferences: Hang up the phone

By

Doctors shared their information preferences with CMI/Compas, revealing ways marketers can better pace their communications to max out channels.

IMS Health gobbles up SaaS firm Appature

By

IMS Health has acquired Seattle-based software-as-a-service (SaaS) company Appature, the firms are expected to announce today.

Docs to pharma marketers: you're not getting it

Docs to pharma marketers: you're not getting it

By

An ePharma Summit panel of physicians takes the sheen off new marketing initiatives by telling pharmas they find them useless.

Merck finds "dual modality" in DTC helps viewers grasp risks

By

A Merck study bolsters FDA's case for requiring that TV ads for prescription drugs present risks in text as well as the voiceover.

SaaS firm signs up agencies, others to analytics/RM platform

By

Seattle-based Appature has signed up several healthcare marketing agencies and business service firms to use its cloud-based relationship marketing platform.

Life science firms wade into Big Data

Life science firms wade into Big Data

By

Pharma companies are starting down the Big Data path but are trying to identify the business questions best suited to new analytic techniques.

Marketing-research budgets on the mend, survey suggests

By

An analysis of a cross-section of the pharma industry shows budgets of pharmaceutical marketing research teams are starting to recover from 2008 lows.

IMS pitches expanded real-world evidence platform to pharma

By

IMS has added claims data to its real-world evidence (RWE) platform, but can it satisfy industry's demand for RWE as well as a payer can?

GPs harried by reps, oncologists not as much

By

Data show detailing pressure and pharmaceutical rep access are still much higher in primary care than in other specialties.

Company news: Lippincott Williams & Wilkins and WorldOne

Lippincott builds out its Nursing Advisor and WorldOne adds a patient-insight component.

McCann Health buys global market research consultancy

By

Double Helix, a healthcare consultancy that operates across three continents, was bought by Interpublic Group's McCann Health, the network said Monday.

Indian conglomerate buys Manhattan Research parent for $635m

By

A Mumbai-based pharma custom manufacturing firm is buying the parent company of Manhattan Research.

Wolters Kluwer deals health analytics unit to private equity firm

By

Symphony Technology Group, a private equity firm, acquired the healthcare analytics business of Wolters Kluwer, the companies said.

Genentech's mind-tapping science moves needle on Pulmozyme, Tamiflu

Genentech's mind-tapping science moves needle on Pulmozyme, Tamiflu

By

Genentech is thinking outside the traditional focus group to understand patients, helping address the long-standing business challenges of adherence and brand preference, the firm says.

Social media an outcomes listening post for pharma

By

FDA issues may deter drugmakers from engaging in social media, but that's no excuse to ignore what audiences are saying on these platforms, say pharma and device firms.

GfK snags Bridgehead in bid to deepen payer expertise

By

Responding to what it calls an "acute need" among clients for market access counsel, GfK is buying Bridgehead International, a consultancy with offices here and abroad.

People news: Novartis, Qforma and Precision Health Media

Novartis named Brian McNamara as division head of OTC, replacing J&J veteran Naomi Kelman, who spent a year in the role.

Legislative wins, but no surety for survey researchers

Legislative wins, but no surety for survey researchers

By

Quite a few states have moved to shield marketing research from regulation. The Supreme Court's ruling on healthcare reform could spur new threats.

InVentiv Health to buy SDI audits from IMS

By

Privately held inVentiv Health will acquire two of SDI Health's audit businesses worth under $15 million, according to company statements. IMS Health agreed to divest the units when regulators approved its purchase of SDI last year.

Aiming for more real-world data, AZ cozies up to IMS Health

By

AstraZeneca has enlisted data supplier IMS Health in an effort to collect evidence on how its treatments are doing outside of controlled clinical trials, firms said.

Company news: Physicians Interactive, WorldOne, Bristol-Myers Squibb and Inhibitex

Physicians Interactive (PI) and WorldOne formed an exclusive strategic alliance to merge their US-based healthcare marketing research panels, firms said.

Firms link to cover digital doctor research front

Firms link to cover digital doctor research front

By

Two powers of the marketing research arena—Epocrates and M3—partnered today to create what they claim is the world's largest verified physician and healthcare provider panel.

Company news: Gilead, Pfizer and Wolters Kluwer

Two potential blockbusters in the pharma pipeline took another step toward reaching market, as US regulatory authorities assigned PDUFA dates for Gilead Sciences' Quad pill and for Pfizer's tofacitinib.

Incivek's $1 bil. in sales this year would set record for fastest launch, analyst says

By

Vertex's drug for treating hepatitis C virus, Incivek (telaprevir), is on course to smash the previous record for the biggest revenue-generating drug launch ever, says an analyst firm.

IMS Health closes SDI deal, must divest two SDI product lines

By

Federal regulators gave IMS Health the go-ahead to buy SDI Health, and IMS's parent company must now divest two SDI product lines.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters